Pulmonary paracoccidioidomycosis.
Queiroz-Telles F, Escuissato DL.
Semin Respir Crit Care Med. 2011 Dec;32(6):764-74. doi: 10.1055/s-0031-1295724. Epub 2011 Dec 13.
New Insights on Pulmonary Paracoccidioidomycosis.
Queiroz-Telles FV, Peçanha Pietrobom PM, Rosa Júnior M, Baptista RM, Peçanha PM.
Semin Respir Crit Care Med. 2020 Feb;41(1):53-68. doi: 10.1055/s-0039-3400544. Epub 2020 Jan 30.
Pulmonary and cerebral paracoccidioidomycosis.
Machado MGL, Rodrigues RS, Marchiori E.
Rev Soc Bras Med Trop. 2022 Sep 19;55:e0188. doi: 10.1590/0037-8682-0188-2022. eCollection 2022.
Pulmonary paracoccidioidomycosis.
Restrepo A, Benard G, de Castro CC, Agudelo CA, Tobón AM.
Semin Respir Crit Care Med. 2008 Apr;29(2):182-97. doi: 10.1055/s-2008-1063857.
A scoping study of pulmonary paracoccidioidomycosis: severity classification based on radiographic and tomographic evaluation.
Ribeiro SM, Nunes TF, Cavalcante RS, Paniago AMM, Pereira BAS, Mendes RP.
J Venom Anim Toxins Incl Trop Dis. 2022 Nov 25;28:e20220053. doi: 10.1590/1678-9199-JVATITD-2022-0053. eCollection 2022.
Paracoccidioidomycosis vaccine.
Travassos LR, Taborda CP.
Hum Vaccin Immunother. 2012 Oct;8(10):1450-3. doi: 10.4161/hv.21283. Epub 2012 Aug 16.
Paracoccidioidomycosis.
Ramos-E-Silva M, Saraiva Ldo E.
Dermatol Clin. 2008 Apr;26(2):257-69, vii. doi: 10.1016/j.det.2007.11.005.
Pulmonary paracoccidioidomycosis in AhR deficient hosts is severe and associated with defective Treg and Th22 responses.
de Araújo EF, Preite NW, Veldhoen M, Loures FV, Calich VLG.
Sci Rep. 2020 Jul 9;10(1):11312. doi: 10.1038/s41598-020-68322-6.
Paracoccidioidomycosis of the central nervous system with pulmonary involvement: typical imaging findings.
Alves Júnior SF, Marchiori E, Ventura N.
Acta Neurol Belg. 2023 Feb;123(1):227-229. doi: 10.1007/s13760-020-01571-4. Epub 2021 Jan 4.
Paracoccidioidomycosis.
Ferreira MS.
Paediatr Respir Rev. 2009 Dec;10(4):161-5. doi: 10.1016/j.prrv.2009.08.001. Epub 2009 Sep 25.
